Form D · Other Health Care
Swing Therapeutics, Inc.
San Francisco, CA · CIK 0001786195
Offering snapshot reported Sep 15, 2025 · SEC filing
- Reported sold
- $3.3M Offering amount: $3.3M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Aug 5, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 15, 2025 | Initial | $3,300,000 | No comparison | 1 | SEC filing |
| Aug 29, 2025 | Initial | $11,377,712 | No comparison | 14 | SEC filing |
| Jul 26, 2022 | Initial | $9,190,000 | No comparison | 5 | SEC filing |
| Jul 26, 2022 | Initial | $10,294,993 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-557483
Source: Form D, filed Sep 15, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Firlik | Director |
| Zack Lynch | Director |
| Corey Mc Cann | Director |
| Michael Rosenbluth | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
548 Market Street, #63989
San Francisco, CA, 94104
San Francisco, CA, 94104